SCHEMBL16596154

SCHEMBL16596154

Cc1cccc2cc(C)n(-c3ccccc3)c(=O)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
CYP1A2 P05177 1/20 0.42
PIK3CD O00329 2/20 0.41
PIK3R1 P27986 1/20 0.41
PIK3CG P48736 1/20 0.41
NOTUM Q6P988 1/20 0.41
NPSR1 Q6W5P4 3/20 0.40
KDM4E B2RXH2 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HKDC1 Q2TB90 1/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MITF O75030 1/20 0.38
PLA2G1B P04054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16596148 0.85 NOTUM (0.48) ALDH1A1CYP1A2PIK3CDNOTUMNPSR1
SCHEMBL16596150 0.84 PIK3CD (0.42) ALDH1A1PIK3CDPIK3R1PIK3CGNOTUM
SCHEMBL16596822 0.84 CYP1A2 (0.41) ALDH1A1CYP1A2PIK3CDPIK3R1PIK3CG
SCHEMBL16596143 0.84 PIK3CD (0.48) ALDH1A1PIK3CDPIK3R1PIK3CGNPSR1
SCHEMBL16596818 0.84 PIK3CD (0.49) ALDH1A1CYP1A2PIK3CDPIK3R1PIK3CG
SCHEMBL12943411 0.83 PIK3CD (0.42) ALDH1A1CYP1A2PIK3CDPIK3R1PIK3CG
SCHEMBL28906680 0.83 TSHR (0.52) ALDH1A1CYP1A2PIK3CDPIK3R1PIK3CG
SCHEMBL16591272 0.82 GAA (0.46) ALDH1A1CYP1A2PIK3CDPIK3R1PIK3CG
SCHEMBL4411785 0.81 PIK3CD (0.49) CYP1A2PIK3CDPIK3R1PIK3CG
SCHEMBL22929161 0.81 PIK3CD (0.41) ALDH1A1CYP1A2PIK3CDPIK3R1PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657007-B2 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC (US) 2017-05-23 US disclosed
US-9512114-B2 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC (US) 2016-12-06 US disclosed
US-20160318914-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2016-11-03 US disclosed
US-20150087658-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2015-03-26 US disclosed
WO-2015042078-A2 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2015-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318914-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, MYD88 ALDH1A1 2302/4885CYP1A2 2122/4885PIK3CD 2/4885
US-20150087658-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, MYD88 ALDH1A1 2302/4885CYP1A2 2122/4885PIK3CD 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.